Medical Condition

prostate carcinoma

Total Trials

8

Recruiting Now

8

Trial Phases

Phase 2, EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for prostate carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — prostate carcinoma Clinical Trials

How many clinical trials are currently recruiting for prostate carcinoma?

ClinicalMetric currently tracks 8 actively recruiting clinical trials for prostate carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for prostate carcinoma?

prostate carcinoma research spans Phase 1 (1 trial), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a prostate carcinoma clinical trial?

Eligibility criteria for prostate carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Top Sponsors

Mayo Clinic 2 trials

Jonsson Comprehensive Cancer Center 2 trials

M.D. Anderson Cancer Center 1 trial

City of Hope Medical Center 1 trial

Emory University 1 trial

Recruiting Clinical Trials

NCT06535802

Recruiting

iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men

Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Jonsson Comprehensive Cancer C...

View Trial →

NCT04947254 Phase 2

Recruiting

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

M.D. Anderson Cancer Center

View Trial →

NCT06541210

Recruiting

Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men

Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy

City of Hope Medical Center

View Trial →

NCT04857502 EARLY_Phase 1

Recruiting

99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

Jonsson Comprehensive Cancer C...

View Trial →

NCT06865768 Phase 2

Recruiting

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Shehzad Basaria, M.D.

View Trial →

Related Conditions

stage iii prostate cancer ajcc v8 (2) androgen deprivation therapy (2) stage iic prostate cancer ajcc v8 (1) stage iiia prostate cancer ajcc v8 (1) stage iiib prostate cancer ajcc v8 (1) stage iiic prostate cancer ajcc v8 (1) stage iva prostate cancer ajcc v8 (1) advanced prostate carcinoma (1) metastatic prostate carcinoma (1) stage iv prostate cancer ajcc v8 (1) recurrent prostate carcinoma (1) prostate cancer (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology